2Sacco RL,Roberts JK,Jacobs BS. Hom ocysteine as arisk factor for ischem icstroke:an epidem iological story in evolution [J]. Neuroepidemiology, 1998,17 (4): 167.
3Boysen G,Brander T,Christensen H,et al. Homocysteine and risk of recurrent stroke[J]. Stroke,2003,34(5) : 1258-1261.
4Martinelli I, Battaglioli T, Pedotti P, et al. Hyperhom ocysteine in cerebral vein thrombosis [J]. Blood, 2003,102 (4) :1363-1366.
5Refsum H, Ueland PM, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med, 1998, 49:31.
6Deloughery TG, Evans A, Sadeghi A, et al. Common mutation methylenetetrahydrofolate reductase. Correlation with hyperhomocysteine metabolism and late-onset vascular disease. Circulation,i996, 94:3074.
7Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In:Seriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York: Mc-Graw-Hill, 1995. 1279.
8Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total hornocysteine concentration and risk of stroke in middle-aged Brltish men. Lancet, 1995, 346:1395.
9Saeco RL, Roberts JK, Jambs BS. Homocysteine as a risk factor for ischemie stroke: an epidemiological story in evolution. Neuroepidemiology, 1998, 17:167.
10Vila N, Deulofeu R, Chamorro A, et al. Plasma homocysteine levels in patients with ischemic cerebral infarction. Med Clin Barc, 1998,110:605.
